Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Compugen Ltd. - Ordinary Shares (NQ:CGEN)

1.775 +0.065 (+3.80%)
Streaming Delayed Price Updated: 11:24 AM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Compugen Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 Next >
News headline image
Compugen Ltd (CGEN) Q3 2021 Earnings Call Transcript ↗
CGEN earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
48 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares climbed 41% to $9.28 after the company reported better-than-expected Q3results and issued Q4 sales guidance above... 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded... 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2021 ↗
Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co... 
Via Benzinga
News headline image
Why Compugen Surged 14% Higher on Thursday ↗
The company is deepening its partnership with Bristol Myers Squibb. 
Via The Motley Fool
News headline image
91 Biggest Movers From Yesterday ↗
Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &... 
Via Benzinga
News headline image
Thursday Market Overview ↗
If you are an IBM shareholder you now own something new Kyndryl. 
Via Talk Markets
News headline image
Election Day ↗
Teva rose a whopping 8.34% today. 
Via Talk Markets
News headline image
Thursday Market Coverage ↗
US jobless benefit applicants last week hit a pandemic low of 290,000, below the estimate of 300,000. 
Via Talk Markets
News headline image
The Secret To Successful Investing In Biotech ↗
Have you ever had a stock jump 30%, 50% or 100% in one day? 
Via Talk Markets
News headline image
Chinese Growth Level ↗
The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues. 
Via Talk Markets
News headline image
More Chinese Trouble ↗
A day after the consumer price rise there was another price rise for producer markets. 
Via Talk Markets
News headline image
Markets Boosted ↗
Good news helped stock prices. 
Via Talk Markets
News headline image
October Starts Positive ↗
A lot of these moves are simply reactions to last month's excesses and they may not be predictive for October at all. 
Via Talk Markets
News headline image
Delta Variant Fears Continue ↗
The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher. 
Via Talk Markets
News headline image
Compugen's Out-Licensed Lung Cancer Candidate Enters Human Trial ↗
AstraZeneca Plc's (NASDAQ: AZN) bispecific antibody derived from Compugen Ltd's (NASDAQ: CGEN) COM902 will advance into clinical development. ... 
Via Benzinga
News headline image
Delta Outbreak ↗
The US market was droopy because of poor private sector jobless numbers. 
Via Talk Markets
News headline image
Know When To Hold 'Em, Know When To Fold 'Em ... ↗
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
News headline image
News Overload ↗
Today US markets managed a rally despite misses in both the growth and employment data. 
Via Talk Markets
News headline image
Why Compugen Stock Is Rising Again Today ↗
Momentum is carrying over from the company's second-quarter update on Wednesday. 
Via The Motley Fool
News headline image
Full News Day ↗
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
News headline image
Compugen Ltd (CGEN) Q2 2021 Earnings Call Transcript ↗
CGEN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Why Compugen Stock Is Jumping Today ↗
Investors were especially interested in the company's pipeline update. 
Via The Motley Fool
News headline image
Containment Plan ↗
Today the US decided to cut China risks. 
Via Talk Markets
News headline image
Delta Defeats Bulls ↗
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
News headline image
Weak Week ↗
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. 
Via Talk Markets
News headline image
Sell Sell Sell ↗
Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday. 
Via Talk Markets
News headline image
People Needed ↗
If qualified people are not looking for work, they will have to be lured to do so with higher wages. 
Via Talk Markets
News headline image
End Of June ↗
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made. 
Via Talk Markets
Topics Initial Public Offering
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.